Evidence map›Paper›PMID 29103043›Full record

ArticleJournal of Alzheimer's disease : JAD2018

Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.

Val Andrew Fajardo, Val Andrei Fajardo, Paul J LeBlanc, Rebecca E K MacPherson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Lithium: current state of the art and future directions.International journal of bipolar disorders · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Lithium and its effects: does dose matter?International journal of bipolar disorders · 2024
    Review
  14. Lithium: how low can you go?International journal of bipolar disorders · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Long-Term Lithium Therapy: Side Effects and Interactions.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Val Andrew FajardoDepartment of Health Sciences, Brock University, St. Catharines, ON, Canada.
Val Andrei FajardoDepartment of Actuarial Sciences, University of Waterloo, Waterloo, ON, Canada.
Paul J LeBlancDepartment of Health Sciences, Brock University, St. Catharines, ON, Canada.
Rebecca E K MacPhersonDepartment of Health Sciences, Brock University, St. Catharines, ON, Canada.
Brock University · CAUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlzheimer's disease (AD) mortality rates have steadily increased over time. Lithium, the current gold standard treatment for bipolar disorder, can exert neuroprotective effects against AD.

objectiveWe examined the relationship between trace levels of lithium in drinking water and changes in AD mortality across several Texas counties.

methods6,180 water samples from public wells since 2007 were obtained and averaged for 234 of 254 Texas counties. Changes in AD mortality rates were calculated by subtracting aggregated age-adjusted mortality rates obtained between 2000-2006 from those obtained between 2009-2015. Using aggregated rates maximized the number of counties with reliable mortality data. Correlational analyses between average lithium concentrations and changes in AD mortality were performed while also adjusting for gender, race, education, rural living, air pollution, physical inactivity, obesity, and type 2 diabetes.

resultsAge-adjusted AD mortality rate was significantly increased over time (+27%, p < 0.001). Changes in AD mortality were negatively correlated with trace lithium levels (p = 0.01, r = -0.20), and statistical significance was maintained after controlling for most risk factors except for physical inactivity, obesity, and type 2 diabetes. Furthermore, the prevalence of obesity and type 2 diabetes positively correlated with changes in AD mortality (p = 0.01 and 0.03, respectively), but also negatively correlated with trace lithium in drinking water (p = 0.05 and <0.0001, respectively).

conclusionTrace lithium in water is negatively linked with changes in AD mortality, as well as obesity and type 2 diabetes, which are important risk factors for AD.

Indexed as

AdultAge FactorsAlzheimer DiseaseDrinking WaterFemaleHumansLithiumLongitudinal StudiesMaleObesityPrevalenceRisk FactorsStatistics as TopicTexasYoung AdultDrinking WaterLithiumDementiaGSK3neuroprotectionobesitytype 2 diabetes

Identifiers

PMID29103043
PMCPMC7592673
OpenAlexW2765476034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.